Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy
Recurrent glioblastoma multiforme (GBM) is a highly aggressive primary malignant brain tumor that is resistant to existing treatments. Recently, we reported that activated autologous natural killer (NK) cell t...